insert_link Health & Wellness Moderna wins full approval for its Covid-19 vaccine, as Novavax seeks authorization for its version As STAT News reports, ever-evolving landscape of Covid-19 vaccines shifted again on Monday, with Moderna winning full approval for its jab from the Food and Drug Administration, and Novavax submitting a long-awaited application to the agency for an emergency use authorization for its vaccine. The approval of Moderna’s vaccine, Spikevax, makes it the country’s second fully licensed vaccine to protect against SARS-CoV-2. It’s also the first product the Cambridge, Mass., […] todayFebruary 2, 2022
insert_link Health & Wellness Concerned about new COVID-19 variants? The FDA is developing a plan to Adapt Concerned about new variants of the virus that causes COVID-19, the U.S. Food and Drug Administration announced late Thursday that it is developing guidance to help vaccine, drug and testing manufacturers adapt. Existing vaccines, treatments and tests still work well, emphasized the FDA's acting commissioner Janet Woodcock. But now is the time to get ready for a future when they may not. "We must prepare for all eventualities," she said […] todayFebruary 11, 2021
insert_link Health & Wellness Why lead COVID vaccines – even with Lower Efficacy – are a Success Across the Board Last week, Johnson & Johnson submitted its COVID-19 vaccine for emergency use in the United States. If greenlit by the Food and Drug Administration, it could be the nation’s third COVID vaccine producer, joining Pfizer and Moderna. Between the three manufacturers, there could be enough COVID vaccines to inoculate the whole adult U.S. population by summer, according to Johnson & Johnson board member Mark McClellan, MD. Last week, Johnson & […] todayFebruary 8, 2021
play_arrow
play_arrow
